Systematic Financial Management LP Sells 91,205 Shares of Sabra Healthcare REIT, Inc. $SBRA

Systematic Financial Management LP reduced its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 4.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,212,509 shares of the real estate investment trust’s stock after selling 91,205 shares during the quarter. Sabra Healthcare REIT comprises about 1.0% of Systematic Financial Management LP’s holdings, making the stock its 26th biggest holding. Systematic Financial Management LP’s holdings in Sabra Healthcare REIT were worth $41,905,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the company. Jefferies Financial Group Inc. bought a new position in shares of Sabra Healthcare REIT in the fourth quarter valued at approximately $321,000. EverSource Wealth Advisors LLC boosted its position in shares of Sabra Healthcare REIT by 48.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 3,891 shares of the real estate investment trust’s stock valued at $74,000 after acquiring an additional 1,267 shares during the period. IFP Advisors Inc boosted its position in shares of Sabra Healthcare REIT by 14.3% in the fourth quarter. IFP Advisors Inc now owns 5,715 shares of the real estate investment trust’s stock valued at $108,000 after acquiring an additional 717 shares during the period. PNC Financial Services Group Inc. boosted its position in shares of Sabra Healthcare REIT by 2.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after acquiring an additional 528 shares during the period. Finally, Handelsbanken Fonder AB boosted its position in shares of Sabra Healthcare REIT by 33.8% in the fourth quarter. Handelsbanken Fonder AB now owns 94,306 shares of the real estate investment trust’s stock valued at $1,786,000 after acquiring an additional 23,800 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on SBRA. Wells Fargo & Company raised their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, March 26th. Citizens Jmp lifted their target price on shares of Sabra Healthcare REIT from $22.00 to $23.00 and gave the company a “market outperform” rating in a research report on Wednesday, February 18th. Cantor Fitzgerald lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a research report on Monday, May 11th. Truist Financial lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a research report on Friday, March 13th. Finally, Citigroup lifted their target price on shares of Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a research report on Wednesday, February 18th. Five analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $22.30.

Sabra Healthcare REIT Trading Up 0.0%

Shares of Sabra Healthcare REIT stock opened at $20.72 on Friday. Sabra Healthcare REIT, Inc. has a 1 year low of $17.08 and a 1 year high of $21.28. The firm has a market cap of $5.23 billion, a PE ratio of 32.89, a PEG ratio of 1.66 and a beta of 0.67. The company has a debt-to-equity ratio of 0.96, a current ratio of 4.72 and a quick ratio of 4.72. The company has a 50 day simple moving average of $20.32 and a two-hundred day simple moving average of $19.63.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its quarterly earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. The firm had revenue of $221.75 million for the quarter, compared to the consensus estimate of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The business’s revenue was up 20.9% compared to the same quarter last year. During the same period last year, the firm posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Stockholders of record on Friday, May 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. The ex-dividend date is Friday, May 15th. Sabra Healthcare REIT’s payout ratio is presently 190.48%.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.